Gaia Coppock, MD, examines why the rapidly evolving treatment landscape for IgA nephropathy can be overwhelming for nephrologists, who face challenges in selecting the best therapies amid frequent ...

Please provide your email address to receive an email when new articles are posted on . Sibeprenlimab-szsi is the first approved A-proliferation-inducing-ligand blocker for adults with IgA nephropathy ...

Dr Dana Rizk discusses Voyxact (sibeprenlimab-szsi), a new FDA-approved treatment to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. Dr ...

Please provide your email address to receive an email when new articles are posted on . Atacicept led to a 45.7% reduction in proteinuria and significant decreases in galactose-deficient IgA1 and ...

IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...

In the final analysis, iptacopan was found to statistically significantly slow IgAN progression compared with placebo. Final results were announced from the phase 3 APPLAUSE-IgAN trial evaluating ...

Source: Getty Images KDIGO’s new guideline on IgA nephropathy highlights its immunologic pathophysiology and encourages early diagnosis and management to prevent or delay end-stage kidney disease.

There is no specific diet created for people with IgAN, but focusing on a low-sodium, whole-food diet can help support overall health. Eating foods low in saturated fat, protein, phosphorus, and ...

IgA nephropathy can shorten life expectancy by 10 years on average. Life expectancy can depend on several factors, including kidney function at diagnosis, protein levels in the urine, age, other ...

Opioids like morphine and oxycodone have long been staples of pain management. But their powerful pain-relieving effects come at a high cost: respiratory depression, dependence, and, in some cases, ...

Traditional steroid-based regimens and some newer therapies showed the most efficacy for clinical remission. A systematic review and network meta-analyses of immunoglobulin (Ig)A nephropathy (IgAN) ...

Opioids like morphine are widely used in medical practice due to their powerful pain-relieving effects, yet they carry the risk of serious adverse effects such as respiratory depression and drug ...